SOLIGENIX, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | — | $119,371 | $839,359 | $948,911 | $824,268 |
| Cost of revenue | — | $119,371 | $742,048 | $550,822 | $728,640 |
| Gross profit | — | — | $97,311 | $398,089 | $95,628 |
| Research and development | $7.5M | $5.2M | $3.3M | $7.9M | $8.2M |
| Operating expenses | $11.8M | $9.4M | $7.8M | $14.6M | $13.2M |
| Operating income | -$11.8M | -$9.4M | -$7.7M | -$14.2M | -$13.1M |
| Pretax income | -$11.6M | -$8.7M | -$7.9M | -$15.0M | -$13.4M |
| Income tax expense | -$506,615 | -$409,114 | -$1.8M | -$1.2M | -$864,742 |
| Net income | -$11.1M | -$8.3M | -$6.1M | -$13.8M | -$12.6M |
| Balance Sheet | |||||
| Cash and equivalents | — | — | — | — | $26.0M |
| Current assets | $8.8M | $8.8M | $9.5M | $13.9M | $26.6M |
| Total assets | $9.2M | $9.0M | $9.8M | $14.3M | $26.9M |
| Current liabilities | $3.7M | $4.8M | $6.2M | $16.5M | $6.3M |
| Total liabilities | $3.9M | $4.8M | $7.3M | $16.8M | $16.1M |
| Stockholders' equity | $5.3M | $4.1M | $2.5M | -$2.5M | $10.7M |
| Cash Flow Statement | |||||
| Cash from operations | -$10.3M | -$8.4M | -$8.6M | -$12.6M | -$11.7M |
| Depreciation and amortization | $3,224 | $5,814 | $6,554 | $24,562 | $34,161 |
| Stock-based compensation | $587,583 | $329,815 | $370,182 | $333,389 | $361,559 |
| Capital expenditure | $5,883 | — | — | — | — |
| Free cash flow | -$10.3M | — | — | — | — |
| Impairments | $0 | $0 | $0 | $0 | — |
Shares outstanding 14.8M · Free float 100.0%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.